Oramed Pharmaceuticals Inc Defensive Interval Ratio

Latest as of March 2026: 1819 days

Oramed Pharmaceuticals Inc defensive interval ratio. Oramed Pharmaceuticals Inc (ORMP) has a Defensive Interval Ratio of 1819 days as of March 2026. Defensive assets of $52.64 Million (cash $-, short-term investments $52.64 Million, receivables $-) cover 1819 days of daily cash needs of $28.94K/day. See how liquid is Oramed Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

1819 days
Days of operational coverage

Defensive Assets

$52.64 Million
Cash + ST Investments + Receivables

Daily Cash Need

$28.94K
Current Liabilities ÷ 365

Current Liabilities

$10.56 Million
USD

Defensive Interval Ratio of Oramed Pharmaceuticals Inc (2008–2025)

Defensive interval ratio of Oramed Pharmaceuticals Inc from 2008 to 2025. This chart shows how Oramed Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 1819 days, meaning defensive assets of $52.64 Million can fund 1819 days of operations without new revenue. Check Oramed Pharmaceuticals Inc (ORMP) asset resilience to evaluate the company's liquid asset resilience ratio.

Oramed Pharmaceuticals Inc Defensive Interval Ratio by Year (2008–2025)

Oramed Pharmaceuticals Inc defensive interval ratio by year from 2008 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Oramed Pharmaceuticals Inc from 2008 to 2025, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Oramed Pharmaceuticals Inc assets under control.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 1618 days $84.58 Million $52.29K/day $- $79.95 Million ▼ -4001 days
2024 5618 days $87.51 Million $15.58K/day $- $87.51 Million ▲ +4569 days
2023 1049 days $152.99 Million $145.79K/day $- $152.99 Million ▼ -6272 days
2022 7321 days $115.26 Million $15.74K/day $- $115.26 Million ▲ +6398 days
2021 923 days $16.89 Million $18.30K/day $- $16.89 Million ▼ -735 days
2020 1658 days $20.60 Million $12.43K/day $- $20.60 Million ▼ -333 days
2019 1991 days $28.95 Million $14.54K/day $- $28.95 Million ▼ -51 days
2018 2042 days $25.47 Million $12.47K/day $- $25.47 Million ▲ +900 days
2017 1141 days $16.15 Million $14.15K/day $- $16.15 Million ▼ -1591 days
2016 2733 days $27.11 Million $9.92K/day $- $27.11 Million ▼ -703 days
2015 3436 days $14.02 Million $4.08K/day $- $14.02 Million ▼ -4043 days
2014 7479 days $19.94 Million $2.67K/day $- $19.53 Million ▲ +2888 days
2013 4591 days $6.27 Million $1.36K/day $- $6.20 Million ▲ +4427 days
2012 163 days $288.41K $1.77K/day $- $200.31K ▼ -624 days
2011 787 days $951.65K $1.21K/day $- $384.56K ▲ +651 days
2010 137 days $171.61K $1.26K/day $- $100.00K ▼ -1287 days
2009 1423 days $1.44 Million $1.01K/day $- $1.00 Million ▲ +334 days
2008 1089 days $2.73 Million $2.50K/day $- $2.73 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)